Cognitive Behavioral Group Therapy for Trichotillomania (Hair Pulling Disorder)

Last updated: March 1, 2024
Sponsor: Oslo University Hospital
Overall Status: Active - Recruiting

Phase

N/A

Condition

Alopecia

Scalp Disorders

Hair Loss

Treatment

Cognitive behavioral therapy

Clinical Study ID

NCT02747771
2013/632
  • Ages 16-67
  • All Genders

Study Summary

This study aims at evaluating the effectiveness of group-based cognitive behavioral therapy for trichotillomania at three clinical sites in Norway.

Eligibility Criteria

Inclusion

  • Inclusion Criteria:
  • Clinical diagnosis of Trichotillomania
  • Age between 16 and 67

Exclusion

  • Exclusion Criteria:
  • schizophrenia spectrum disorder
  • substance addiction
  • severe antisocial, schizotypal, or paranoid personality disorder
  • severe eating disorder,
  • ongoing suicidal ideation
  • pervasive developmental disorder
  • mental retardation and severe sequelae after brain injury.

Study Design

Total Participants: 150
Treatment Group(s): 1
Primary Treatment: Cognitive behavioral therapy
Phase:
Study Start date:
January 01, 2013
Estimated Completion Date:
December 31, 2026

Study Description

The Norwegian Trichotillomania Project is a multicenter study that aims at evaluating the effectiveness of behavioral group therapy for TTM, i.e., ACT (Acceptance and commitment therapy) enhanced habit reversal training (ACT-enhanced HRT).

Participants are adults or adolescents (16 year or older) who fulfill criteria for TTM according to DSM-IV. Inclusion started in January 2013 and will be completed by Mai 2016. Treatment is delivered at three treatment sites in Norway; in Kristiansand, Oslo, and Trondheim. Treatment is manualized, following the manual of Twohig and Woods, and consists of ten group sessions of three hours delivered at consecutive weeks, and two or three booster sessions during the first year after treatment.

Treatment outcome is evaluated by three outcome measures; the Massachusetts General Hospital

  • Hairpulling Scale (self-report); the National Institute of Mental Health Trichotillomania Severity Scale (clinical interview, conducted by independent evaluators); and the Clinical Global Impression Scale for TTM. Outcome is measured at three points in time; at baseline, at the end of treatment, and at one-year follow-up. Mixed models procedures in SPSS is used to analyze longitudinal data.

The first paper will be written on patients admitted to treatment from January 2013 to September 2014, and includes 53 patients (49 women and four men). By January 2016, fifty-one patients (96%) had participated in the one-year follow-up evaluation.

Connect with a study center

  • Oslo University Hospital

    Oslo, 0607
    Norway

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.